Published in Lancet Neurol on November 01, 2013
PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis (PINNACLE) | NCT03507374
Routine clinical evaluation of cerebrovascular reserve capacity using carbogen in patients with intracranial stenosis. Stroke (2014) 0.98
Postmortem Study of Validation of Low Signal on Fat-Suppressed T1-Weighted Magnetic Resonance Imaging as Marker of Lipid Core in Middle Cerebral Artery Atherosclerosis. Stroke (2016) 0.80
Correlation of intracranial atherosclerosis with carotid stenosis in ischemic stroke patients. Ann Indian Acad Neurol (2015) 0.80
Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients. BMC Neurol (2015) 0.78
Carotid and vertebral artery stenosis evaluated by contrast-enhanced MR angiography in nasopharyngeal carcinoma patients after radiotherapy: a prospective cohort study. Br J Radiol (2015) 0.78
Intake of antioxidants and B vitamins is inversely associated with ischemic stroke and cerebral atherosclerosis. Nutr Res Pract (2016) 0.77
Remote ischaemic conditioning-a new paradigm of self-protection in the brain. Nat Rev Neurol (2015) 0.77
Treatment and imaging of intracranial atherosclerotic stenosis: current perspectives and future directions. Brain Behav (2016) 0.76
Increased pulsatility of the intracranial blood flow spectral waveform on transcranial Doppler does not point to peripheral arterial disease in stroke patients. J Stroke Cerebrovasc Dis (2014) 0.75
Safety and Efficacy Analyses of Angioplasty and Stenting for Severe Intracranial Arterial Stenosis: A Single-Center Retrospective Study in China. Med Sci Monit (2015) 0.75
Vessel wall differences between middle cerebral artery and basilar artery plaques on magnetic resonance imaging. Sci Rep (2016) 0.75
Quantifying Intracranial Internal Carotid Artery Stenosis on MR Angiography. AJNR Am J Neuroradiol (2017) 0.75
Internal carotid artery stenting for intracranial atherosclerosis. Methodist Debakey Cardiovasc J (2015) 0.75
RNA interference therapy: a new solution for intracranial atherosclerosis? Ann Transl Med (2014) 0.75
Spanning from the West to East: An Updated Review on Endovascular Treatment of Intracranial Atherosclerotic Disease. Aging Dis (2017) 0.75
Angioplasty and stenting for patients with symptomatic intracranial atherosclerosis: study protocol of a randomised controlled trial. BMJ Open (2016) 0.75
A Prospective Study of Asymptomatic Intracranial Atherosclerotic Stenosis in Neurologically Normal Volunteers in a Japanese Cohort. Front Neurol (2016) 0.75
Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease: a nationwide retrospective cohort study (J-ASPECT study). BMJ Open (2016) 0.75
Local blood pressure associates with the degree of luminal stenosis in patients with atherosclerotic disease in the middle cerebral artery. Biomed Eng Online (2016) 0.75
Endovascular Stroke Therapy Focused on Stent Retriever Thrombectomy and Direct Clot Aspiration: Historical Review and Modern Application. J Korean Neurosurg Soc (2017) 0.75
Moderate- to high-intensity statins for secondary prevention in patients with type 2 diabetes mellitus on dialysis after acute myocardial infarction. Diabetol Metab Syndr (2017) 0.75
High-resolution vessel wall MRI for the evaluation of intracranial atherosclerotic disease. Neuroradiology (2017) 0.75
Multiparametric estimation of brain hemodynamics with MR fingerprinting ASL. Magn Reson Med (2016) 0.75
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet (2001) 17.97
High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79
Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med (2012) 8.39
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92
Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med (1985) 5.53
Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke (1995) 4.54
A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol (2000) 4.29
Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation (2006) 4.21
The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology (2008) 3.77
The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology (2007) 3.24
US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke (2007) 3.17
Global burden of intracranial atherosclerosis. Int J Stroke (2006) 2.98
Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol (2010) 2.97
Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol (1998) 2.90
Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology (1989) 2.74
A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke (2007) 2.70
Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke (2008) 2.68
Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol (2011) 2.62
Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation (2007) 2.50
Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology (2005) 2.45
Race and sex differences in the distribution of cerebral atherosclerosis. Stroke (1996) 2.35
Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol (2005) 2.19
Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology (2012) 2.19
The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology (1995) 2.10
Indirect revascularization for nonmoyamoya intracranial arterial stenoses: clinical and angiographic outcomes. J Neurosurg (2012) 2.03
Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology (2007) 1.97
Intracranial arterial wall imaging using high-resolution 3-tesla contrast-enhanced MRI. Neurology (2009) 1.95
In vivo high-resolution MR imaging of symptomatic and asymptomatic middle cerebral artery atherosclerotic stenosis. Atherosclerosis (2010) 1.90
Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke (2006) 1.83
Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology (1990) 1.82
Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg (1993) 1.81
Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology (2003) 1.81
Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study. Stroke (2005) 1.81
Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol (1997) 1.75
Studies in cerebrovascular disease. III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system. Proc Staff Meet Mayo Clin (1955) 1.58
Race-ethnic differences in stroke risk factors among hospitalized patients with cerebral infarction: the Northern Manhattan Stroke Study. Neurology (1995) 1.55
Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg (1999) 1.46
Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. J Neurointerv Surg (2012) 1.45
Basilar artery stent angioplasty for symptomatic intracranial athero-occlusive disease: complications and late midterm clinical outcomes. AJNR Am J Neuroradiol (2007) 1.44
Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke (1995) 1.26
Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke (1999) 1.24
High-resolution magnetic resonance imaging: an emerging tool for evaluating intracranial arterial disease. Stroke (2012) 1.23
Arterial remodeling of advanced basilar atherosclerosis: a 3-tesla MRI study. Neurology (2010) 1.22
Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol (2005) 1.20
The association of cigarette smoking with enhanced platelet inhibition by clopidogrel. J Am Coll Cardiol (2008) 1.20
Atherosclerotic disease of the middle cerebral artery. Stroke (1987) 1.18
How accurate is CT angiography in evaluating intracranial atherosclerotic disease? Stroke (2008) 1.16
Is hypoperfusion an important cause of strokes? If so, how? Cerebrovasc Dis (2006) 1.14
High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology (2004) 1.13
Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis (2009) 1.13
Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology (2006) 1.13
Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke (2008) 1.11
Intracranial percutaneous transluminal angioplasty for arteriosclerotic stenosis. Arch Neurol (2000) 1.10
Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design. Int J Stroke (2010) 1.09
Noninvasive fractional flow on MRA predicts stroke risk of intracranial stenosis. J Neuroimaging (2014) 1.08
Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology (2006) 1.05
Stroke in young black patients. Risk factors, subtypes, and prognosis. Stroke (1995) 1.03
Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke (2011) 1.03
Complications of intracranial bypass for vertebrobasilar insufficiency. J Neurosurg (1989) 1.02
Transcranial Doppler: clinical and experimental uses. Cerebrovasc Brain Metab Rev (1992) 1.02
Percutaneous transluminal angioplasty in the treatment of atherosclerotic disease of the anterior cerebral circulation and hemodynamic evaluation. J Neurosurg (1995) 1.01
Intracranial vertebrobasilar stenosis: angioplasty and follow-up. AJNR Am J Neuroradiol (2000) 1.01
Angioplasty for intracranial symptomatic vertebrobasilar ischemia. Neurosurgery (2002) 0.97
Predictors of intracranial carotid artery atherosclerosis. Duration of cigarette smoking and hypertension are more powerful than serum lipid levels. Arch Neurol (1991) 0.96
Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis. Stroke (2008) 0.96
The use of balloon-expandable stents in the management of intracranial arterial diseases: a 5-year single-center experience. AJNR Am J Neuroradiol (2005) 0.94
Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis (2012) 0.92
Cerebral atherosclerosis--a comparative autopsy study between Nigerian Negroes and American Negroes and Caucasians. Neurology (1969) 0.91
Adiponectin levels in patients with intracranial atherosclerosis. Neurology (2007) 0.91
Long-term Outcomes of Drug-eluting Stents in Symptomatic Intracranial Stenosis. Neurointervention (2013) 0.90
Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke. Stroke (2012) 0.90
Significance of good collateral compensation in symptomatic intracranial atherosclerosis. Cerebrovasc Dis (2012) 0.90
Association between changes in lipid profiles and progression of symptomatic intracranial atherosclerotic stenosis: a prospective multicenter study. Stroke (2012) 0.89
Drug eluting stents for symptomatic intracranial and vertebral artery stenosis. Interv Neuroradiol (2011) 0.88
Simultaneous occurrence and interaction of hypoperfusion and embolism in a patient with severe middle cerebral artery stenosis. Stroke (2009) 0.88
Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting. J Neurointerv Surg (2009) 0.86
Imaging of intracranial plaques with black-blood double inversion recovery MR imaging and CT. J Neuroimaging (2011) 0.84
The effectiveness of dual antiplatelet treatment in acute ischemic stroke patients with intracranial arterial stenosis: a subgroup analysis of CLAIR study. Int J Stroke (2012) 0.84
Clinical and angiographic comparison of asymptomatic occlusive cerebrovascular disease. Neurology (1988) 0.81
Lipoprotein-associated phospholipase A2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease. Atherosclerosis (2011) 0.81
ETIOLOGIC MECHANISMS IN CEREBRAL ATHEROSCLEROSIS. PRELIMINARY STUDY OF 3,839 CASES. Arch Neurol (1964) 0.80
Magnetic resonance angiography findings in patients with ischemic stroke from North India. J Stroke Cerebrovasc Dis (2010) 0.79
Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era. Postgrad Med (2013) 0.79
Intracranial steno-occlusive arterial disease and its associations in Egyptian ischemic stroke patients. Stroke (2012) 0.77
Clinical characteristics of transient ischemic attacks in black patients. Neurology (1991) 0.76
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation (2006) 4.21
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87
Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis (2011) 2.70
Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol (2011) 2.62
Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke (2007) 1.81
Endovascular treatment for acute ischemic stroke--still unproven. N Engl J Med (2013) 1.68
Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke (2002) 1.63
Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Circ Cardiovasc Qual Outcomes (2012) 1.63
Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery (2013) 1.58
Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke (2009) 1.54
Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. Cerebrovasc Dis (2014) 1.51
Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association. Circulation (2015) 1.48
Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. J Neurointerv Surg (2012) 1.45
High-resolution magnetic resonance imaging: an emerging tool for evaluating intracranial arterial disease. Stroke (2012) 1.23
Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N Am (2007) 1.20
Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke (2008) 1.11
Collateral circulation in symptomatic intracranial atherosclerosis. J Cereb Blood Flow Metab (2010) 1.08
Noninvasive fractional flow on MRA predicts stroke risk of intracranial stenosis. J Neuroimaging (2014) 1.08
Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J Neuroimaging (2011) 1.07
Risk factors associated with severity and location of intracranial arterial stenosis. Stroke (2010) 1.05
Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch Neurol (2008) 1.03
Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke. Stroke (2012) 0.90
Treatment of atherosclerotic intracranial arterial stenosis. Stroke (2009) 0.89
MUSC's comprehensive stroke program: changing what's possible in stroke care across South Carolina. J S C Med Assoc (2013) 0.88
Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis. Cerebrovasc Dis (2014) 0.83
Utilization of CT perfusion patient selection for mechanical thrombectomy irrespective of time: a comparison of functional outcomes and complications. J Neurointerv Surg (2012) 0.82
Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis. Cerebrovasc Dis (2007) 0.81
Systemic risk factors associated with progression of atherosclerosis from the coronary to the carotid arteries. J Stroke Cerebrovasc Dis (2007) 0.80
Intracerebral hemorrhage: an unusual presentation of neurosarcoidosis. Neurologist (2011) 0.78
REACH MUSC: A Telemedicine Facilitated Network for Stroke: Initial Operational Experience. Front Neurol (2012) 0.78
Intracranial stenting: SAMMPRIS. Stroke (2013) 0.76
Central retinal venous occlusion and cerebral venous thrombosis. Arch Neurol (2007) 0.75
Game changer for endovascular treatment of acute ischemic stroke? J Neurointerv Surg (2014) 0.75
Echocardiography in patients with symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis (2007) 0.75
In reply: Is there a contribution of anesthesia to the outcome of the SAMMPRIS trial? Neurosurgery (2014) 0.75
Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis? Cerebrovasc Dis (2016) 0.75
The challenge of stroke prevention with intracranial arterial stenosis. Curr Cardiol Rep (2013) 0.75
Practical approach to management of intracranial atherosclerosis. Curr Treat Options Cardiovasc Med (2015) 0.75
A clinical example of the "limping brain" syndrome: a case report. AJNR Am J Neuroradiol (2005) 0.75
Vessel and Vessel Wall Imaging. Front Neurol Neurosci (2016) 0.75
Angioplasty and Stenting. Front Neurol Neurosci (2016) 0.75
Cerebral Venous Sinus Thrombosis Due to Low-molecular-weight Heparin-induced Thrombocytopenia. Neurologist (2017) 0.75
Treatment of intracranial atherosclerotic stenosis. Rev Neurol Dis (2008) 0.75
Light-induced Hemiplegia, an Atypical Case of Retinal Steal Syndrome. Neurologist (2017) 0.75
10 questions about intracranial atherosclerotic stenosis. Neurologist (2010) 0.75